Literature DB >> 11493452

Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.

R Yatuv1, N Rosenberg, A Zivelin, H Peretz, R Dardik, L Trakhtenbrot, U Seligsohn.   

Abstract

The most frequent mutation causing Glanzmann thrombasthenia in Iraqi-Jews (IJ-1) is an 11-bp deletion in exon 13 of the glycoprotein (GP) IIIa gene. This deletion predicts a frameshift that results in the elimination of the C406-C655 disulfide bond and a premature termination codon shortly before the transmembrane domain. To determine the contribution of each of these alterations to the thrombasthenic phenotype, Chinese hamster ovary or baby hamster kidney cells were cotransfected with normal GPIIb complementary DNA (cDNA) and the following GPIIIa cDNAs: normal, cDNA bearing IJ-1 mutation, 2011T>A mutated cDNA predicting C655S (single-letter amino acid codes) substitution, and 2019A>T mutated cDNA predicting Stop657. Elimination of the C406-C655 disulfide bond by C655S substitution did not affect GPIIb/IIIa surface expression or binding of the transfected cells to immobilized fibrinogen, whereas elimination of the transmembrane and cytoplasmic domains in IJ-1 and Stop657 mutants prevented both surface expression and binding of the transfected cells to immobilized fibrinogen. Immunohistochemical staining and immunoprecipitation demonstrated that the elimination of amino acids 657-762 in IJ-1 and Stop657 prevented intracellular GPIIb/IIIa complex formation, and differential immunofluorescence staining of GPIIIa and cellular organelles suggested that the truncated uncomplexed GPIIIa protein was retained in the endoplasmic reticulum. Because the use of GPIIIa Stop693 and normal GPIIb cDNAs yielded GPIIb/IIIa complex formation, though with lower efficiency, it is suggested that amino acids 657-692 of GPIIIa are essential for the intracellular association of GPIIb and GPIIIa. (Blood. 2001;98:1063-1069)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493452     DOI: 10.1182/blood.v98.4.1063

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia.

Authors:  N Rosenberg; H Hauschner; H Peretz; R Mor-Cohen; M Landau; B Shenkman; G Kenet; B S Coller; A A Awidi; U Seligsohn
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

2.  Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families.

Authors:  Paolo Gresele; Emanuela Falcinelli; Silvia Giannini; Pio D'Adamo; Angela D'Eustacchio; Teresa Corazzi; Anna Maria Mezzasoma; Filomena Di Bari; Giuseppe Guglielmini; Luca Cecchetti; Patrizia Noris; Carlo L Balduini; Anna Savoia
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

3.  Glanzmann thrombasthenia associated with a 21-amino acid deletion (Leu817-Gln837) in glycoprotein IIb due to abnormal splicing in exon 25.

Authors:  Tetsuro-Takahiro Fujimoto; Mihoko Sora; Kazuko Ide; Miyoko Mizushima; Masashi Mita; Shinichiro Nishimura; Kazuhiro Ueda; Kingo Fujimura
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

4.  A rare case of bleeding disorder: Glanzmann's thrombasthenia.

Authors:  Jami Swathi; A Gowrishankar; S A Jayakumar; Karun Jain
Journal:  Ann Afr Med       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.